| Table 4. Number (%) of centers routinely performing diagnostic tests on their clinical staff or patients before the start of ovarian stimulation. | ||||||
| July n=155 |
Aug n=181 |
Sept n=147 |
Oct n=110 |
Nov n=137 | Dec n=98 |
|
|---|---|---|---|---|---|---|
| Patients -Antibody tests (IgG /IgM) only -PCR nasopharynx swab |
24 (15.5) 37 (23.9) |
38 (21.0) 60 (33.2) |
51 (46.3) 72 (49.0) |
31 (28.1) 55 (50.0) |
43 (31.15) 77 (56.2) |
27 (27.55) 50 (51.0) |
| Clinical Staff -PCR nasopharynx swab and/or antibodies (IgG and IgM) |
49 (31.6) | 75 (41.4) | 62 (42.2) | 15 (13.6) | 53 (38.71) | 35 (35.7) |